Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
215 participants
INTERVENTIONAL
2009-06-30
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to compare ventricular septal pacing to no pacing in patients with SND.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance
NCT01798043
LVSP vs RVP in Patients With AV Conduction Disorders
NCT04595487
RV Septal Versus Minimized RV Pacing in Sick Sinus Syndrome
NCT01477138
Evaluation of Pacemaker Algorithms to Avoid Unnecessary Right Ventricular Pacing
NCT01803217
Comparison of the Efficacy and Safety of Cardioneuroablation to Permanent Pacing in Patients With an Implanted Pacemaker for Symptomatic Bradycardia.
NCT05896592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No pacing
Ventricular intrinsic conduction enhanced
VIP
Ventricular pacing must be less than 10%.
Pacing
Septal ventricular pacing with optimized AV delay
Septal ventricular pacing
Ventricular pacing must be at least 90%, from the septum and with optimized AV delay
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Septal ventricular pacing
Ventricular pacing must be at least 90%, from the septum and with optimized AV delay
VIP
Ventricular pacing must be less than 10%.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Permanent atrial fibrillation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Pontchaillou - CCP
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-A01266-49
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.